Duke University Hospital

Research CenterTreats all valves

AI Description

Duke’s Valve and Structural Heart Program evaluates and treats aortic, mitral, tricuspid, and other structural heart conditions, with cardiologists, interventional cardiologists, and cardiac surgeons working together. Care includes valve repair and replacement, open, minimally invasive, robotic, and transcatheter procedures such as TAVR and percutaneous mitral valve repair, along with imaging, monitoring, second opinions, and clinical-trial evaluation.

This description was generated by AI based on public sources. Data Sources and Methodology · Report inaccurate information

Location and Contact

2301 Erwin Rd
Durham, NC 27705

Clinical Trials

Active, not recruiting

SURTAVI

Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).

Public sites
56
Start date
Apr 1, 2012
Active, not recruiting

TRICAV-I

TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)

Public sites
34
Start date
Jul 23, 2024
Active, not recruiting

PRIMARY

Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)

Public sites
22
Start date
Feb 21, 2022
Active, not recruiting

PORTICO-IDE

Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial

Public sites
59
Start date
May 1, 2014
Recruiting

APOLLO

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Public sites
71
Start date
Oct 23, 2017

Nearby Centers